Search Results - stefan+radtke

3 Results Sort By:
Targeted delivery into CD90+ cells
Selection and Use of Hematopoietic Stem Cells for Cell Transplantation and Gene Therapy Approaches Defined population predicts and quantitatively correlates with <em>in vivo</em> engraftment and multilineage potential. Hematopoietic stem cells (HSC) are the preferred target population for <em>ex vivo</em> gene therapy...
Published: 8/28/2024   |   Updated: 8/28/2024   |   Inventor(s): Stefan Radtke, HanS-Peter Kiem, Kurt Berckmueller, Roland Strong, Peter Rupert
Keywords(s): HSC Therapy, Lentiviral, Small Molecule, Target, Vectors
Category(s): Research Tool, Gene Therapy
Human and Nonhuman Primate Hematopoietic Stem/Repopulating Cells and Methods for Enriching The Same
Selection and Use of Hematopoietic Stem Cells for Cell Transplantation and Gene Therapy Approaches Defined population predicts and quantitatively correlates with <em>in vivo</em> engraftment and multilineage potential. Hematopoietic stem cells (HSC) are the preferred target population for <em>ex vivo</em> gene therapy...
Published: 4/16/2025   |   Updated: 8/28/2024   |   Inventor(s): HanS-Peter Kiem, Jennifer Adair, Stefan Radtke
Keywords(s): HSC Therapy
Category(s): Cell Therapy, Gene Therapy
Luteinizing hormone as a means of promoting HSC expansion ex vivo
Methods to Target Hematopoietic Stem Cells for Ablation or Expansion Luteinizing hormone receptor (LHR) binding agents and luteinizing hormone (LH) agonists to target and expand HSCs. Hematopoietic stem cell transplant (HCT) has been curative for many cancer malignancies and monogenetic diseases. However, current clinical limitations include...
Published: 2/4/2025   |   Updated: 10/4/2017   |   Inventor(s): Jarrod Dudakov, Marcel Van Den Brink, Enrico Velardi, HanS-Peter Kiem, Stefan Radtke, Scott James
Keywords(s): Assay / Method, HSC Therapy
Category(s): Cell Therapy, Research Tool, Therapeutic
© 2025. All Rights Reserved. Powered by Inteum